Predict Allocates 251,500 Shares Under 2025 Stock Grant Plan and Lifts Lock-Up

The latest update is out from Predict S.P.A. Class B ( (IT:PRE) ).

Predict S.p.A. has allocated 251,500 newly issued ordinary shares under its 2025 Stock Grant Plan to key employees, executing a free share capital increase that raises its share capital from €130,390 to €134,751.07 and brings the total number of shares to 7,771,000. The Board of Directors also decided to fully waive the 24‑month lock‑up period originally attached to the granted shares, potentially increasing the liquidity of the stock for beneficiaries. Following the allocation, Predict will update and file its amended Articles of Association and publish formal notice of the capital change in the Companies Register of Bari, signaling the company’s use of equity incentives to support growth and development objectives in its med‑tech business.

The most recent analyst rating on (IT:PRE) stock is a Buy with a EUR1.45 price target. To see the full list of analyst forecasts on Predict S.P.A. Class B stock, see the IT:PRE Stock Forecast page.

More about Predict S.P.A. Class B

Predict S.p.A., founded in 2008 in Bari, is an Italian innovative SME in the med‑tech sector focused on in vivo diagnostics through the distribution of ultrasound and radiological equipment and the development of advanced breath-analysis and digital healthcare technologies. Organized into four strategic business units covering imaging support, breath analysis (Mistral), and digital health solutions such as AI‑enabled robotics and augmented reality tools for doctors, the company targets cutting‑edge healthcare applications and collaborates with major Italian university hospitals and research institutes.

Average Trading Volume: 22,775

Technical Sentiment Signal: Strong Buy

Current Market Cap: €6.3M

Learn more about PRE stock on TipRanks’ Stock Analysis page.